Vandana Singh - Spark Newswire

1 minute read

Uncategorized

Zogenix’s Fintepla Associated With Improvements in Seizure Control, Executive Functions In Childhood Epilepsy Disorder

April 22, 10:51 AM

Zogenix Inc (NASDAQ: ZGNX) has announced new data showing the positive impact of treatment with Fintepla (fenfluramine) on everyday executive function for…

ZGNX

1 minute read

Uncategorized

Renalytix AI Stock Jumps After 10-Year US Government Contract For Kidney Disease Testing Services

By Vandana Singh

April 22, 7:58 AM

Renalytix AI plc (NASDAQ: RNLX) stock is rising on the heels of a 10-year contract from the United States Government to provide…

RNLX

1 minute read

Uncategorized

AstraZeneca’s MEDI5884-PCSK9 Inhibitor Combo Shows Promise In Heart Disease

By Vandana Singh

April 22, 6:56 AM

Most heart disease drugs are aimed at reducing the "bad" low-density lipoprotein (LDL) cholesterol. However, strategies related to cutting LDL cholesterol and increasing high-density lipoprotein (HDL) cholesterol are of interest in combating the risk of heart disease.

AZN

1 minute read

Uncategorized

Novo Nordisk To Start Phase 3 Obesity Trial With Oral Semaglutide

By Vandana Singh

April 21, 1:53 PM

Novo Nordisk A/S (NYSE: NVO) is entering the Phase 3a study in obesity with oral semaglutide 50 mg. The decision follows the…

NVO

1 minute read

Uncategorized

Brii Biosciences, Vir Biotech, VBI Vaccines Start Combination Therapy Hepatitis B Study

By Vandana Singh

April 21, 8:50 AM

Privately-held Brii Biosciences, Vir Biotechnology Inc (NASDAQ: VIR), and VBI Vaccines Inc (NASDAQ: VBIV) have dosed the first patient in a Phase 2 trial evaluating BRII-835 (VIR-2218) in combination…

VBIV

1 minute read

Uncategorized

Trevena’s TRV027 Included In Global COVID-19 Study

By Vandana Singh

April 21, 7:55 AM

Trevena Inc (NASDAQ: TRVN) has announced that its novel AT1 receptor-selective agonist, TRV027, has been selected for inclusion in an international Phase…

TRVN

1 minute read

Uncategorized

Anixa’s Stock Craters As FDA Slaps Clinical Hold On CAR-T Program

By Vandana Singh

April 19, 12:58 PM

Anixa Biosciences Inc (NASDAQ: ANIX) shares drop after the FDA has requested additional information on its Chimeric Antigen Receptor-T cell therapy (CAR-T)…

1 minute read

Uncategorized

Humanigen’s Lenzilumab Shows Encouraging Response Rate In Blood Cancer Study

By Vandana Singh

April 19, 7:58 AM

Humanigen Inc (NASDAQ: HGEN) has announced data from the Phase 1b portion of the ZUMA-19 trial evaluating its lead candidate lenzilumab in patients treated…